Evidence Feed

About

Diagnostics

New

Top genes

FAQ

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

CBM-C20.1

ⁱ

Other names: CART-20, anti-CD20 chimeric antigen receptor T cell therapy, anti-CD20 CART cells, CAR-CD20 T cell therapy, CART20, CBM-C20.1

News alerts, weekly reports and conference planners

Associations

News

Trials

Company:

AbelZeta Pharma

Drug class:

CD20-targeted CAR-T immunotherapy

Related drugs:

‹

4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR (0)

4SCAR-T (0)

Anti-CD19/CD20/CD22 CAR T-Cells (0)

CAR-20/19-T Cells (0)

CAR-T CD19/CD20/CD22/CD30 (0)

CAR20.19.22 T (0)

CART20 (0)

CD19/CD20 CAR T-cells (0)

CD20-CART (0)

CD20-CD19 cCAR T cells (0)

autologous TriCAR T (0)

bbT369 (0)

multi-CAR-T cell therapy (0)

sequential different B cell antigen-targeted CAR T-cell therapy (0)

MB-CART2019.1 (0)